{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:40:20Z","timestamp":1760082020085,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.endien.2025.501631","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:23:50Z","timestamp":1759879430000},"page":"501631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuromedin U and BMI correlation in T1DM and T2DM vs healthy controls: A comparative study"],"prefix":"10.1016","volume":"72","author":[{"given":"Yasemin","family":"\u00c7al\u0131\u015fkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Sarand\u00f6l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizameddin","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2025.501631_bib0095","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.3390\/ijms22084238","article-title":"Neuromedin U, a key molecule in metabolic disorders","volume":"22","author":"Teranishi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.endien.2025.501631_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1900\/RDS.2011.8.355","article-title":"Peptides and their potential role in the treatment of diabetes and obesity","volume":"8","author":"Greenwood","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.endien.2025.501631_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2019.04.020","article-title":"Circulating Neuromedin U levels are similar in subjects with NGT and newly diagnosed T2DM and do not correlate with insulin secretion","volume":"151","author":"Han","year":"2019","journal-title":"Diabet Res Clin Pract"},{"key":"10.1016\/j.endien.2025.501631_bib0110","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/en.2010-1463","article-title":"Effects of peripherally administered Neuromedin U on energy and glucose homeostasis","volume":"152","author":"Peier","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.endien.2025.501631_bib0115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2017.08.132","article-title":"Neuromedin U suppresses glucose-stimulated insulin secretion in pancreatic \u03b2 cells","volume":"493","author":"Zhang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.endien.2025.501631_bib0120","doi-asserted-by":"crossref","first-page":"e0250232","DOI":"10.1371\/journal.pone.0250232","article-title":"Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.endien.2025.501631_bib0125","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/en.2009-0448","article-title":"Neuromedin S and U","volume":"150","author":"Novak","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.endien.2025.501631_bib0130","doi-asserted-by":"crossref","first-page":"773000","DOI":"10.3389\/fmed.2022.773000","article-title":"Insights into the research status of Neuromedin u: a bibliometric and visual analysis from 1987 to 2021","volume":"9","author":"Qi","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.endien.2025.501631_bib0135","doi-asserted-by":"crossref","first-page":"713961","DOI":"10.3389\/fendo.2021.713961","article-title":"Neuromedins NMU and NMS: an updated overview of their functions","volume":"12","author":"Malendowicz","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2025.501631_bib0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20050248","article-title":"The neuropeptide Neuromedin U promotes inflammation by direct activation of mast cells","volume":"202","author":"Moriyama","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.endien.2025.501631_bib0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm1106","article-title":"Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway","volume":"10","author":"Hanada","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.endien.2025.501631_bib0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1373\/clinchem.2014.231753","article-title":"Neuromedin U: a multifunctional neuropeptide with pleiotropic roles","volume":"61","author":"Martinez","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.endien.2025.501631_bib0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.endien.2025.501631_bib0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.emboj.7600526","article-title":"Identification of Neuromedin S and its possible role in the mammalian circadian oscillator system","volume":"24","author":"Mori","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.endien.2025.501631_bib0165","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1021\/acs.jmedchem.7b00330","article-title":"Potent body weight-lowering effect of a Neuromedin U receptor 2-selective pegylated peptide","volume":"60","author":"Kanematsu-Yamaki","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.endien.2025.501631_bib0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bph.14077","article-title":"Differential effects of selective agonists of Neuromedin U1 and U2 receptors in obese and diabetic mice","volume":"175","author":"Nagai","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.endien.2025.501631_bib0175","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1210\/en.2002-220121","article-title":"Evaluation of Neuromedin U actions in energy homeostasis and pituitary function","volume":"143","author":"Ivanov","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.endien.2025.501631_bib0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuron.2016.01.007","article-title":"A zebrafish genetic screen identifies Neuromedin U as a regulator of sleep\/wake states","volume":"89","author":"Chiu","year":"2016","journal-title":"Neuron"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802500109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802500109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:23:36Z","timestamp":1760081016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253001802500109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S253001802500109X"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2025.501631","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromedin U and BMI correlation in T1DM and T2DM vs healthy controls: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2025.501631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501631"}}